Jamieson Wellness Inc. (TSE:JWEL - Get Free Report) Senior Officer Joel Scales sold 1,044 shares of the company's stock in a transaction dated Monday, May 26th. The shares were sold at an average price of C$35.06, for a total transaction of C$36,603.06.
Joel Scales also recently made the following trade(s):
- On Friday, May 30th, Joel Scales purchased 480 shares of Jamieson Wellness stock. The stock was purchased at an average cost of C$35.35 per share, with a total value of C$16,968.00.
- On Thursday, March 13th, Joel Scales purchased 1,906 shares of Jamieson Wellness stock. The stock was purchased at an average cost of C$28.34 per share, with a total value of C$54,016.04.
Jamieson Wellness Trading Up 0.7%
Shares of Jamieson Wellness stock traded up C$0.26 during mid-day trading on Friday, hitting C$35.71. The stock had a trading volume of 107,535 shares, compared to its average volume of 75,780. The firm has a market cap of C$1.50 billion, a P/E ratio of 37.52 and a beta of 0.63. Jamieson Wellness Inc. has a 12-month low of C$26.00 and a 12-month high of C$38.20. The company has a quick ratio of 1.08, a current ratio of 2.76 and a debt-to-equity ratio of 75.70. The firm has a 50-day moving average of C$32.12 and a two-hundred day moving average of C$33.25.
Jamieson Wellness Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, March 14th were issued a dividend of $0.21 per share. The ex-dividend date was Friday, March 7th. This represents a $0.84 dividend on an annualized basis and a yield of 2.35%. Jamieson Wellness's dividend payout ratio (DPR) is presently 88.26%.
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada increased their price target on shares of Jamieson Wellness from C$40.00 to C$42.00 in a research note on Friday, May 9th.
Read Our Latest Stock Analysis on JWEL
About Jamieson Wellness
(
Get Free Report)
Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment.
Read More
Before you consider Jamieson Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jamieson Wellness wasn't on the list.
While Jamieson Wellness currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
